Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (21-30 of 361) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|February 28, 2019
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. ReplyLeora Horn, Stephen V Liu
Translational Lung Cancer Research|November 19, 2020
Novel <i>ALK</i> mutation with durable response to brigatinib-a case reportHira Latif, Stephen V Liu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2019
First-line EGFR TKI therapy in non-small-cell lung cancer: looking back before leaping forwardC Kim, S V Liu
Med (New York, N.Y.)|November 9, 2024
ADRIATIC: When face value is enoughAlfredo Addeo, Stephen V Liu
Infection and Immunity|December 1, 1978
Biological activities of pyochelins: iron-chelating agents of Pseudomonas aeruginosaP V Liu, F Shokrani
The Journal of Infectious Diseases|January 1, 1971
An enterotoxin of Pseudomonas aeruginosaY Kubota, P V Liu
Physical Review Letters|April 6, 2001
Antiferromagnetic spin ladders effectively coupled by one-dimensional electron liquidsW V Liu, E Fradkin
The Journal of Infectious Diseases|October 1, 1973
Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin AP V Liu, H Hsieh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Zipalertinib in <i>EGFR</i> Exon 20-Mutant Non-Small-Cell Lung Cancer: Drug Development in a Rare but Crowded SettingCharu Aggarwal, Stephen V Liu
Journal of Clinical Microbiology|May 1, 1990
Three new major somatic antigens of Pseudomonas aeruginosaP V Liu, S Wang
Pageof 37

Showing results (21-30 of 361) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|February 28, 2019
Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. ReplyLeora Horn, Stephen V Liu
Translational Lung Cancer Research|November 19, 2020
Novel <i>ALK</i> mutation with durable response to brigatinib-a case reportHira Latif, Stephen V Liu
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2019
First-line EGFR TKI therapy in non-small-cell lung cancer: looking back before leaping forwardC Kim, S V Liu
Med (New York, N.Y.)|November 9, 2024
ADRIATIC: When face value is enoughAlfredo Addeo, Stephen V Liu
Infection and Immunity|December 1, 1978
Biological activities of pyochelins: iron-chelating agents of Pseudomonas aeruginosaP V Liu, F Shokrani
The Journal of Infectious Diseases|January 1, 1971
An enterotoxin of Pseudomonas aeruginosaY Kubota, P V Liu
Physical Review Letters|April 6, 2001
Antiferromagnetic spin ladders effectively coupled by one-dimensional electron liquidsW V Liu, E Fradkin
The Journal of Infectious Diseases|October 1, 1973
Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin AP V Liu, H Hsieh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Zipalertinib in <i>EGFR</i> Exon 20-Mutant Non-Small-Cell Lung Cancer: Drug Development in a Rare but Crowded SettingCharu Aggarwal, Stephen V Liu
Journal of Clinical Microbiology|May 1, 1990
Three new major somatic antigens of Pseudomonas aeruginosaP V Liu, S Wang
Pageof 37